Sorin Group has announced that the first US implant of Solo Smart was performed by David Heimansohn, St. Vincent’s Heart Hospital, Indianapolis, USA. The Solo Smart is the first and only valve with a removable stent to be approved in the US market.
The bioprosthesis, made from bovine pericardium, has no synthetic material added, allowing it to mimic the healthy native aortic valve. Solo Smart maximises blood flow and delivers excellent haemodynamic performance, while providing the ease of implantability of a stented valve.
Heimansohn comments: “I am excited to have the Sorin Solo Smart stentless valve available to my patients. Solo Smart is a step forward in the treatment of aortic valve disease, as this surgical valve has superior hemodynamic performance, and is much easier to implant, requiring only a single suture line. It more resembles a native aortic valve in appearance and performance, offering the best hsemodynamics during all conditions, and improving patients’ lives dramatically.”
Solo Smart is the next generation of the Freedom Solo valve, which has been available in Europe since 2004.